Monoclonal antibodies against nitrated nerve growth factor reveal an oxidation-dependent pathogenic hallmark in ALS.
Varela V, Garcimartín S, Trias E, Zeida A, Richter M, de León A, Miquel E, King PH, Vulliez-Le Normand B, Martinez M, Alzari PM, Bartesaghi S, Radi R, Barbeito L
The online reader was unable to display this document directly. This may occur if the repository host is temporarily unreachable, or if security restrictions (CORS) prevent embedded viewing.